Hospitalizations among Veterans treated for metastatic prostate cancer with abiraterone or enzalutamide

Abstract: BACKGROUND: Abiraterone and enzalutamide are second generation androgen receptor pathway inhibitors (ARPIs) used to treat advanced or metastatic prostate cancer. Without …